Overview
Keizo Umegaki practices practicing medicine in Tokyo, Japan.
Their clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Folate Deficiency, Diarrhea, and Nonalcoholic Steatohepatitis (NASH).
They are actively involved in clinical research, co-authoring 71 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Keizo Umegaki
Is Keizo Umegaki a top-rated expert for Non-Alcoholic Fatty Liver Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Keizo Umegaki is classified as an Experienced expert for Non-Alcoholic Fatty Liver Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Keizo Umegaki participate in research or clinical trials?
Yes. Keizo Umegaki has published 71 articles and abstracts on conditions like Non-Alcoholic Fatty Liver Disease. You can view a list of Keizo Umegaki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- DiarrheaUmegaki isExperienced. Learn about Diarrhea.
- Folate DeficiencyUmegaki isExperienced. Learn about Folate Deficiency.
- Non-Alcoholic Fatty Liver DiseaseUmegaki isExperienced. Learn about Non-Alcoholic Fatty Liver Disease.
- Nonalcoholic Steatohepatitis (NASH)